sever
key
point
guid
provid
manag
patient
suspect
cn
infect
first
import
develop
plan
diagnost
workup
clinician
recommend
first
test
like
keyword
mening
enceph
diagnost
metagenom
sequenc
patient
central
nervou
system
cn
infect
experi
high
level
morbid
mortal
part
mani
challeng
inher
diagnosi
cn
infect
identif
caus
pathogen
clinic
present
cn
infect
nonspecif
clinician
must
often
order
interpret
mani
diagnost
test
parallel
daunt
task
given
larg
number
potenti
pathogen
avail
differ
test
modal
review
tradit
diagnost
techniqu
includ
gram
stain
cultur
serolog
polymeras
chain
reaction
pcr
highlight
recommend
pathogen
commonli
test
among
us
patient
suspect
cn
infect
final
describ
newer
broadrang
diagnost
approach
multiplex
pcr
metagenom
sequenc
increasingli
use
clinic
practic
serolog
test
wide
use
diagnosi
cn
infect
particularli
pathogen
present
low
level
brief
period
time
diseas
whose
manifest
primarili
mediat
host
antibodi
respons
inflammatori
syndrom
central
nervou
system
cn
mening
enceph
myeliti
confer
high
morbid
mortal
cn
inflammatori
syndrom
infecti
noninfecti
caus
distinguish
critic
guid
treatment
presenc
absenc
infect
clearli
determin
base
symptom
physic
examin
routin
laboratori
imag
studi
clinician
must
therefor
reli
microbiolog
test
identifi
potenti
caus
pathogen
often
challeng
endeavor
patient
highli
symptomat
extrem
low
organ
burden
optim
diagnost
test
strategi
differ
pathogen
reflect
divers
mechan
infect
variabl
immun
respons
multipl
factor
affect
test
perform
includ
diseas
preval
nuanc
specif
platform
complex
often
lead
clinician
util
patchwork
test
strength
limit
tradit
microbiolog
method
cultur
low
sensit
use
diagnosi
bacteri
fungal
infect
molecular
assay
polymeras
chain
reaction
pcr
specif
improv
sensit
rel
cultur
serolog
test
use
detect
immun
respons
pathogen
distinguish
past
current
infect
challeng
pcr
serolog
requir
clinician
choos
target
pathogen
newer
diagnost
modal
biofir
filmarray
meningitisenceph
syndrom
panel
famep
biomerieux
marcyletoil
franc
metagenom
sequenc
allow
test
multipl
pathogen
simultan
expens
rel
lowthroughput
current
form
review
techniqu
applic
commonli
test
pathogen
among
us
patient
suspect
cn
infect
ca
nt
miss
pathogen
given
patient
know
optim
test
use
pathogen
firstlin
test
unrev
save
cerebrospin
fluid
csf
use
followup
test
diagnost
plan
place
prior
obtain
lumbar
punctur
lp
desir
firstlin
test
sent
extran
test
use
preciou
csf
specif
recommend
intern
enceph
consortium
includ
record
lp
open
pressur
collect
least
cc
csf
save
cc
futur
test
test
csf
sampl
glucos
along
pair
peripher
glucos
protein
white
blood
cell
wbc
count
differenti
red
blood
cell
count
import
collect
larg
volum
csf
ask
clinic
laboratori
save
portion
underestim
facilit
addit
workup
common
caus
infect
rule
prevent
need
repeat
lp
interpret
result
confound
antiinfect
antiinflammatori
treatment
addit
csf
studi
import
gather
corrobor
evid
cn
infect
peripher
site
broadli
eg
blood
cultur
direct
fashion
eg
serolog
serum
human
immunodefici
viru
hiv
test
particularli
import
consid
sinc
differenti
diagnosi
cn
infect
broader
immunocompromis
patient
baselin
serum
also
store
futur
test
sinc
infect
diagnos
test
acut
convalesc
week
sera
close
bidirect
commun
clinic
pathologist
microbiolog
chemistri
laboratori
paramount
ensur
optim
diagnost
assay
chosen
test
follow
time
fashion
valu
csf
chemistri
cell
count
lie
primarili
abil
rapidli
establish
presenc
absenc
cn
inflamm
though
caution
taken
interpret
test
immunocompromis
patient
may
marker
neuroinflamm
classic
teach
viral
pathogen
lead
predominantli
lymphocyt
pleocytosi
bacteri
etiolog
result
neutrophil
predomin
low
glucos
oversimplif
dynam
process
signific
overlap
exampl
pediatr
seri
patient
neutrophil
predomin
csf
posit
predict
valu
neg
predict
valu
distinguish
bacteri
viral
mening
convers
patient
meningococc
mening
normal
csf
wbc
count
despit
certain
pattern
use
guid
test
particularli
firstlin
test
uninform
exampl
includ
moder
low
csf
glucos
level
typic
mump
lymphocyt
choriomening
viru
lcmv
persist
neutrophil
pleocytosi
found
west
nile
viru
wnv
cytomegaloviru
cmv
eosinophil
pleocytosi
rais
concern
helminth
infect
thermal
dimorph
fungu
coccidioid
also
describ
caus
mild
elev
csf
eosinophil
whether
pleocytosi
present
patient
undergo
lp
due
concern
infect
csf
gram
stain
cultur
perform
sensit
gram
stain
depend
organ
burden
rang
listeria
monocytogen
upward
streptococcu
pneumonia
sensit
drop
patient
alreadi
receiv
antibiot
posit
gram
stain
highli
specif
bacteri
mening
specif
bacteri
cultur
also
high
nearli
howev
sensit
vari
pathogen
decreas
increas
interv
antibiot
exposur
lp
neisseria
meningitidi
steril
within
hour
treatment
pneumonia
detect
hour
initi
treatment
albeit
low
sensit
sensit
cultur
tubercul
mening
estim
increas
perform
four
largevolum
ml
lp
primari
drawback
result
provid
clinic
action
timefram
due
slow
growth
rate
mycobacteria
small
number
pathogen
diagnos
use
gram
stain
cultur
clinician
must
reli
heavili
pathogendirect
test
challeng
sever
differ
type
test
modal
use
combin
multitud
potenti
pathogen
summar
prefer
altern
diagnost
test
common
pathogen
discuss
greater
detail
unfortun
streamlin
rulesofthumb
guid
select
particular
test
particular
pathogen
help
understand
pathophysiolog
differ
organ
caus
cn
diseas
gener
choos
pathogenspecif
test
clinician
must
take
account
pathogen
interrog
test
eg
serolog
vs
pcr
look
eg
csf
vs
blood
test
eg
need
pair
acuteconvalesc
sera
anoth
import
consider
turnaround
time
order
test
receiv
result
sinc
clinic
decis
often
need
made
empir
await
test
result
gener
pcr
test
rapid
often
avail
inhous
special
serolog
test
may
avail
refer
laboratori
howev
substanti
variat
clinic
microbiolog
laboratori
close
commun
laboratori
personnel
essenti
sever
consider
interpret
presenc
absenc
antibodi
csf
acut
infect
csf
immunoglobulin
igm
gener
diagnost
intrathec
antibodi
product
sinc
igm
cross
bloodbrain
barrier
well
although
blood
introduc
csf
sampl
lp
lead
falseposit
result
igm
antibodi
crossreact
virus
within
famili
eg
flaviviru
serolog
gener
conduct
two
step
first
often
screen
enzym
immunoassay
eia
patient
sampl
allow
bind
immobil
antigen
secondari
antibodi
target
immunoglobulin
igm
immunoglobulin
often
captur
first
reduc
background
potenti
crossreact
immunoglobulin
g
igg
sampl
posit
screen
eia
undergo
confirmatori
test
eg
plaqu
reduct
neutral
test
prnt
serial
dilut
patient
sampl
mix
viru
incub
cell
cultur
look
plaqu
format
contrast
igm
igg
cross
bloodbrain
barrier
diagnosi
chronic
reactiv
infect
requir
demonstr
elev
csf
serum
igg
ratio
normal
csf
serum
ratio
albumin
test
antibodi
respons
serum
also
aid
diagnosi
must
interpret
care
sinc
prior
vaccin
treatment
blood
product
lead
falseposit
result
case
igg
avid
use
distinguish
recent
infect
low
avid
prior
infect
vaccin
high
avid
final
interpret
result
serolog
test
critic
consid
factor
lead
falseneg
result
treatment
b
cell
deplet
immunotherapi
serolog
techniqu
describ
essenti
establish
diagnosi
rna
arthropodborn
virus
arbovirus
common
unit
state
wnv
cn
manifest
wnv
includ
enceph
mening
acut
flaccid
myeliti
afm
wnv
replic
blood
csf
often
preced
onset
evalu
neurolog
symptom
therefor
wnv
pcr
csf
gener
unreli
establish
diagnosi
report
sensit
though
may
higher
immunocompromis
patient
instead
wnv
usual
diagnos
serolog
test
algorithm
compris
screen
eia
follow
confirmatori
prnt
test
perform
csf
serum
per
center
diseas
control
prevent
cdc
guidelin
establish
diagnosi
neuroinvas
wnv
requir
one
follow
virusspecif
igm
antibodi
csf
neg
csf
igm
endem
arbovirus
virusspecif
igm
antibodi
serum
confirmatori
virusspecif
neutral
antibodi
pair
acut
convalesc
serum
demonstr
fourfold
greater
chang
virusspecif
antibodi
titer
isol
viru
demonstr
specif
viral
antigen
nucleic
acid
import
consider
diagnost
test
wnv
igm
aris
day
onset
ill
persist
month
year
therefor
find
posit
igm
indic
recent
infect
wnv
pathogen
varieti
domest
arbovirus
transmit
mosquito
includ
california
serogroup
california
enceph
viru
jamestown
canyon
viru
snowsho
hare
viru
la
cross
viru
common
children
eastern
equin
enceph
viru
st
loui
enceph
viru
tickborn
enceph
virus
unit
state
includ
powassan
viru
colorado
tick
fever
viru
latter
common
children
detail
regard
neurotrop
arbovirus
worldwid
reader
refer
venkatesan
et
al
common
includ
japanes
enceph
viru
jev
tickborn
enceph
viru
neurotrop
arbovirus
gener
diagnos
serolog
use
criteria
describ
wnv
though
pcr
may
use
eg
jev
brucellosi
zoonot
infect
caus
gram
neg
bacteria
genu
brucella
patient
brucellosi
cn
symptom
includ
mening
enceph
psychiatr
disord
sensorineur
hear
loss
neuropathi
radicul
myeliti
gold
standard
diagnosi
serolog
use
serum
agglutin
test
sat
origin
develop
sat
sensit
specif
nonneurolog
brucella
infect
patient
neurobrucellosi
sat
csf
sensit
specif
although
sat
gold
standard
diagnosi
neurobrucellosi
limit
complex
decreas
sensit
earli
infect
crossreact
gramneg
pathogen
difficulti
interpret
area
high
preval
distinguish
prior
versu
chronic
infect
csf
enzymelink
immunosorb
assay
elisa
often
use
altern
sensit
rang
specif
sensit
csf
cultur
low
rang
diagnosi
also
made
blood
bone
marrow
cultur
sensit
rang
acut
infect
decreas
time
pcr
assay
also
shown
promis
result
yet
valid
serolog
test
given
brucella
highli
contagi
clinician
notifi
microbiolog
laboratori
ensur
proper
biosafeti
measur
taken
bartonella
hensela
gramneg
bacillu
caus
catscratch
diseas
transmiss
asymptomat
bacterem
cat
approxim
patient
catscratch
diseas
develop
neurolog
manifest
primarili
lymphocyt
meningoenceph
neuroretin
character
sudden
onset
unilater
loss
vision
stellat
macular
exud
fundoscopi
infect
hiv
patient
occas
lead
neuropsychiatr
disord
serolog
mainstay
diagnosi
b
hensela
infect
differ
method
wide
vari
perform
elisa
sensit
depend
prepar
techniqu
whether
igg
igm
test
pcr
assay
avail
refer
laboratori
center
perform
serolog
pcr
patient
cn
infect
underexplor
appear
equival
common
manifest
spirochet
bacteria
gener
diagnos
serolog
treponema
pallidum
caus
syphili
involv
cn
secondari
tertiari
late
stage
cn
manifest
secondari
syphili
includ
headach
meningismu
asymmetr
paraparesi
hyperreflexia
neurogen
bladder
visual
hear
loss
facial
weak
late
neurosyphili
present
meningovascular
involv
seizur
strokelik
syndrom
parenchym
involv
tabe
dorsali
gener
paresi
atyp
present
includ
tempor
lobe
enceph
mimic
herp
simplex
viru
hsv
enceph
syphili
diagnos
serolog
first
screen
perform
use
serum
treponem
test
fluoresc
treponem
antibodi
absorpt
ftaab
pallidum
particl
agglutin
tppa
antitreponem
elisa
use
diagnos
syphili
stage
remain
posit
life
regardless
treatment
neg
diagnosi
neurosyphili
rule
posit
nontreponem
test
use
confirm
activ
infect
monitor
treatment
respons
vener
diseas
research
laboratori
vdrl
rapid
plasma
reagin
test
assess
antibodi
react
endogen
antigen
lecithin
cholesterol
cardiolipin
neurosyphili
diagnos
csf
vdrl
specif
sensit
test
perform
csf
low
sensit
includ
pcr
ftaab
elisa
though
tppa
may
promis
therefor
even
csf
vdrl
neg
patient
posit
syphili
serolog
csf
pleocytosi
compat
symptom
treat
presumpt
neurosyphili
borrelia
burgdorferi
caus
lyme
diseas
includ
neuroborreliosi
earli
neuroborreliosi
symptom
unit
state
includ
lymphocyt
mening
seventh
nerv
cranial
neuriti
pain
radiculoneuropathi
patient
clear
cn
infect
without
treatment
develop
late
lyme
neuroborreliosi
month
year
later
syndrom
defin
continu
symptom
occur
month
character
chronic
mening
enceph
myeliti
cerebr
vascul
earli
late
neuroborreliosi
diagnos
demonstr
intrathec
antibodi
product
use
csf
serum
antibodi
index
patient
csf
pleocytosi
antibodi
index
sensit
patient
least
week
symptom
patient
less
week
symptom
therefor
initi
test
neg
high
clinic
suspicion
antibodi
index
repeat
nearli
patient
neuroborreliosi
posit
serum
lyme
test
neg
altern
diagnos
consid
lyme
serolog
repeat
csf
pcr
low
sensit
routin
use
result
csf
antibodi
test
interpret
caution
test
perform
patient
without
compat
symptom
given
potenti
fals
posit
area
endem
antibodi
index
remain
elev
year
success
treatment
leptospirosi
zoonot
infect
caus
leptospira
speci
peopl
come
contact
urin
tissu
infect
anim
contamin
environment
materi
soil
water
first
phase
infect
attribut
hematogen
dissemin
character
high
fever
myalgia
conjunctiv
suffus
second
phase
occur
day
later
includ
asept
mening
attribut
immun
respons
direct
detect
pathogen
blood
csf
possibl
acut
phase
ill
dark
field
microscopi
special
cultur
pcr
howev
practic
diagnosi
made
serolog
acut
phase
usual
recogn
gold
standard
diagnosi
microagglutin
test
mat
fourfold
increas
titer
acut
convalesc
sera
singl
titer
least
set
compat
symptom
highli
suggest
infect
sensit
mat
increas
time
acut
phase
day
specif
report
affect
crossreact
antibodi
spirochet
virus
elisa
igm
report
high
sensit
specif
low
endem
area
perform
poorli
patient
acut
phase
come
endem
area
earli
result
modifi
later
flow
assay
shown
promis
rapid
diagnosi
includ
possibl
earli
mening
mening
seriou
complic
dissemin
infect
endem
fungi
coccidioid
immiti
coccidioid
posadasii
histoplasma
capsulatum
csf
cultur
posit
case
make
serolog
mainstay
diagnosi
igm
igg
detect
csf
use
twotier
test
first
eia
sensit
rel
nonspecif
follow
confirmatori
complement
fixat
immunodiffus
specif
insensit
sever
recent
studi
highlight
potenti
use
antigen
direct
detect
pathogen
assay
current
us
food
drug
administr
fda
approv
toxoplasma
gondii
protozoan
human
acquir
ingest
undercook
meat
handl
contamin
cat
litter
transplacent
except
congenit
toxoplasmosi
manifest
cn
ill
primarili
occur
due
reactiv
latent
infect
patient
defect
tcellmedi
immun
acquir
immunodefici
syndrom
aid
hematolog
malign
exposur
antitumor
necrosi
factor
therapi
solid
organ
transplant
common
cn
present
enceph
chorioretin
first
step
establish
gondii
infect
determin
patient
serostatu
neg
igg
make
toxoplasm
enceph
extrem
unlik
igg
posit
imag
studi
consist
toxoplasmosi
ie
multipl
ringenhanc
lesion
patient
treat
empir
imag
show
singl
lesion
patient
clinic
worsen
despit
treatment
csf
pcr
recommend
sensit
csf
pcr
rang
neg
clinic
suspicion
remain
high
may
necessari
pursu
biopsi
microscop
examin
csf
wet
mount
use
protozo
infect
includ
ameb
meningoenceph
naegleria
fowleri
caus
primari
ameb
meningoenceph
individu
warm
freshwat
exposur
balamuthia
less
commonli
acanthamoeba
caus
indol
granulomat
ameb
meningoenceph
addit
direct
visual
microscopi
special
test
tissu
pcr
immunohistochemistri
also
avail
cdc
east
african
trypanosomiasi
caus
sleep
sick
diagnos
direct
visual
trypanosom
csf
brain
tissu
blood
contrast
serolog
use
diagnos
american
trypanosomiasi
caus
chaga
diseas
includ
rare
meningoenceph
helminth
infect
also
occasion
detect
direct
visual
angiostrongylu
cantonensi
rat
lungworm
caus
acut
eosinophil
mening
ingest
snail
contamin
food
though
histor
common
tropic
infect
increasingli
detect
unit
state
helminth
infect
associ
eosinophil
mening
includ
baylisascari
gnathostoma
paragonimu
toxocara
schistosoma
rare
identifi
direct
visual
csf
diagnosi
often
involv
combin
presumpt
clinic
diagnosi
serolog
review
walker
zunt
graeffteixeira
et
al
direct
detect
microbi
antigen
compris
protein
glycoprotein
occasion
use
good
exampl
cryptococc
antigen
test
crag
cryptococcu
neoforman
caus
mening
patient
defect
cellmedi
immun
includ
aid
solid
organ
transplant
advanc
malign
prolong
exposur
highdos
steroid
sarcoidosi
relat
cryptococcu
gattii
caus
mening
immunocompet
patient
detect
crag
direct
polysaccharid
capsul
test
highli
sensit
specif
commerci
avail
assay
posit
neg
predict
valu
initi
titer
prognost
valu
follow
serial
monitor
treatment
respons
patient
lp
access
contraind
world
health
organ
recommend
substitut
serum
crag
assess
later
flow
assay
latex
agglutin
platform
serum
crag
sensit
specif
rel
csf
crag
cultur
sever
rapid
antigenbas
assay
bacteri
mening
introduc
turn
centuri
disappoint
perform
advent
molecular
techniqu
approach
larg
fallen
favor
pcr
detect
pathogen
nucleic
acid
amplifi
short
region
genom
use
primer
design
match
conserv
nucleotid
sequenc
method
requir
extract
nucleic
acid
often
combin
amplif
singl
assay
pcr
perform
directli
dna
use
detect
rna
addit
revers
transcript
rt
step
rtpcr
distinct
realtim
pcr
also
known
quantit
pcr
clinic
pcr
test
quantit
eg
hiv
viral
load
pcr
test
use
diagnos
cn
infect
qualit
provid
posit
neg
result
pcr
test
wide
implement
cn
diagnost
highli
specif
inexpens
much
rapid
cultur
review
tunkel
et
al
debiasi
tyler
mani
pcr
test
excel
sensit
falseneg
result
rare
occur
due
inhibitor
heme
degrad
product
individu
pcr
test
requir
sampl
howev
multipl
differ
test
run
total
sampl
volum
limit
mani
dna
virus
caus
cn
infect
human
herpesvirus
hhv
gener
acquir
earli
life
cn
manifest
occur
primari
infect
frequent
viru
becom
latent
neuron
cell
reactiv
caus
cn
diseas
diagnosi
cn
infect
herpesvirus
therefor
frequent
depend
direct
detect
viral
dna
pcr
rather
serolog
sinc
mani
patient
seroposit
baselin
hsv
among
common
pathogen
cn
infect
affect
immunocompet
patient
caus
enceph
primarili
involv
limbic
region
much
less
commonli
caus
mening
commonli
caus
mening
recurr
less
commonli
also
caus
enceph
primarili
neonat
well
lumbosacr
radicul
transvers
myeliti
diagnos
pcr
test
separ
eg
use
typespecif
primer
togeth
eg
use
melt
curv
analysi
test
characterist
pcr
extens
studi
overal
show
excel
sensit
specif
though
sensit
may
lower
neonat
sensit
may
also
low
within
first
day
infect
infecti
diseas
societi
america
guidelin
recommend
repeat
lp
hsv
pcr
day
first
test
neg
high
clinic
suspicion
repeat
test
inform
even
empir
treatment
sinc
sensit
remain
high
first
day
start
acyclovir
varicella
zoster
viru
vzv
caus
chicken
pox
primari
infect
shingl
reactiv
associ
mani
cn
syndrom
postinfecti
cerebellar
ataxia
children
primari
infect
myeliti
associ
primari
infect
reactiv
optic
neuriti
vasculopathi
mening
enceph
vzv
enceph
occur
often
immunocompromis
patient
includ
necrot
ventricul
case
pathophysiolog
vzv
enceph
believ
due
smallvessel
vasculopathi
vzv
smallvessel
vasculopathi
manifest
multifoc
ischem
stroke
aneurysm
hemorrhag
vzv
also
caus
largevessel
arter
lead
stroke
immunocompet
patient
particularli
herp
zoster
ophthalmicu
vzv
vasculopathi
difficult
diagnos
occur
without
typic
dermatolog
manifest
month
rash
diagnosi
cn
vzv
diseas
gener
reli
upon
pcr
serolog
vzv
pcr
csf
variabl
sensit
rang
patient
vasculopathi
patient
meningoenceph
may
delay
viral
express
csf
onset
neurolog
symptom
syndrom
repres
antibodymedi
diseas
therefor
vzv
serolog
csf
import
addit
test
includ
csf
igm
syndrom
aris
primari
vzv
infect
csf
serum
igg
ratio
syndrom
associ
vzv
reactiv
due
complex
test
vzv
clinician
recommend
discuss
optim
test
order
expect
turnaround
time
microbiolog
laboratori
epsteinbarr
viru
ebv
caus
enceph
mening
immunocompromis
patient
also
caus
myeliti
cerebel
sequela
primari
infect
immunocompet
patient
ebv
diagnos
csf
pcr
find
ebv
dna
csf
conclus
evid
diseas
sinc
ebv
also
reactiv
set
anoth
inflammatori
process
although
overal
rare
may
occur
commonli
immunocompromis
patient
therefor
syndrom
associ
primari
ebv
infect
recommend
also
check
peripher
serolog
one
compel
indic
pcr
distinguish
ebvrel
cn
lymphoma
mass
lesion
immunocompromis
patient
set
ebv
pcr
csf
sensit
specif
cmv
caus
enceph
necrot
associ
hemorrhag
ventricul
well
cn
manifest
retin
lumbosacr
radiculomyel
diagnosi
made
pcr
csf
sensit
specif
find
cmv
tissu
support
diagnosi
cmv
reactiv
often
involv
multipl
organ
often
caus
limbic
enceph
immunocompromis
patient
particularli
recent
undergon
stem
cell
transplant
may
also
caus
seizur
children
primari
infect
though
controversi
diagnosi
made
pcr
find
dna
csf
conclus
evid
diseas
dna
found
brain
tissu
sampl
asymptomat
individu
posit
predict
valu
find
dna
csf
part
like
herpesvirus
acquir
earli
life
establish
latent
infect
reactiv
particularli
set
infect
addit
unlik
herpesvirus
also
integr
human
genom
occur
within
telomer
call
chromosom
integr
approxim
popul
acquir
birth
express
everi
cell
bodi
lead
asymptomat
highgrad
express
therefor
pcr
csf
posit
also
recommend
test
whole
blood
find
would
argu
pathogen
interpret
result
posit
csf
pcr
often
requir
judici
interpret
take
account
clinic
radiograph
present
well
likelihood
altern
diagnos
nonherp
dna
virus
also
caus
cn
infect
adenoviru
infect
children
immunocompromis
patient
particularli
undergon
stem
cell
transplant
adenoviru
caus
enceph
less
commonli
mening
diagnos
pcr
csf
posit
pcr
respiratori
sampl
also
support
diagnosi
john
cunningham
jc
viru
polyomaviru
gener
acquir
earli
life
remain
latent
kidney
viru
reactiv
invad
cn
immunocompromis
patient
particular
aid
receiv
natalizumab
multipl
sclerosi
classic
cn
present
jc
viru
progress
multifoc
leukoencephalopathi
syndrom
alter
mental
statu
focal
neurolog
deficit
due
discret
brain
lesion
often
bilater
asymmetr
develop
periventricular
subcort
white
matter
jc
viru
also
rare
caus
mening
encephalopathi
cerebellar
granul
cell
neuronopathi
jc
viru
diagnos
csf
pcr
specif
sensit
rang
depend
clinic
scenario
sensit
lower
hiv
patient
receiv
antiretrovir
therapi
brain
biopsi
immunohistochemistri
electron
microscopi
higher
yield
obtain
less
frequent
noninvas
test
gener
use
adult
seroposit
jc
viru
even
pcr
serum
urin
posit
mani
immunosuppress
patient
without
cn
diseas
risk
jc
viru
reactiv
risk
stratif
jc
viru
serolog
titer
recommend
patient
receiv
natalizumab
cn
infect
caus
rna
virus
gener
occur
manifest
primari
infect
sinc
rna
virus
becom
latent
reactiv
rna
virus
pcr
use
detect
viral
rna
csf
other
best
diagnos
use
serolog
short
period
viral
replic
enterovirus
common
caus
asept
mening
also
caus
enceph
notabl
recurr
meningoenceph
children
hypogammaglobulinemia
highli
divers
group
compris
multipl
strain
enterovirus
ev
well
echovirus
coxsackievirus
b
polioviru
nonpolio
ev
diagnos
use
rtpcr
assay
target
conserv
region
viral
genom
region
enteroviru
pcr
excel
sensit
specif
overal
estim
exceed
except
much
less
reliabl
detect
csf
pcr
one
case
seri
csf
sampl
posit
case
high
suspicion
enteroviru
neg
csf
pcr
support
diagnosi
also
achiev
enteroviru
pcr
test
respiratori
tract
stool
parechoviru
relat
group
picornaviru
famili
caus
mening
young
children
diagnos
rtpcr
separ
assay
enteroviru
rna
virus
diagnos
csf
pcr
includ
lcmv
caus
mening
less
commonli
enceph
patient
expos
hous
mice
acut
convalesc
serolog
obtain
high
suspicion
lcmv
neg
pcr
hiv
multipl
cn
manifest
includ
asept
mening
acut
infect
enceph
due
immun
reconstitut
inflammatori
syndrom
chronic
dementia
diagnos
csf
pcr
quantit
viral
load
may
inform
unvaccin
individu
measl
rare
caus
enceph
month
infect
subacut
scleros
panenceph
insidi
syndrom
incub
period
sever
year
measl
diagnos
pcr
csf
brain
tissu
serolog
pcr
cultur
nasopharynx
urin
mump
caus
mening
unvaccin
individu
diagnos
csf
pcr
cultur
serolog
rabi
viru
caus
almost
uniformli
fatal
enceph
patient
experi
bite
exposur
rabid
mammal
incub
period
exposur
onset
ill
vari
greatli
due
need
viru
migrat
cn
peripher
nervou
system
site
exposur
diagnosi
rabi
made
perform
rtpcr
histor
immunohistochemistri
biopsi
either
brain
skin
hairlin
nape
neck
addit
diagnost
modal
includ
rabi
rtpcr
saliva
rabi
serolog
csf
serum
howev
serolog
low
sensit
confound
patient
receiv
either
vaccin
postexposur
prophylaxi
although
mani
bacteria
diagnos
growth
csf
cultur
pcr
help
fastidi
organ
case
patient
receiv
prior
antibiot
treatment
good
exampl
tropheryma
whipplei
actinomycet
bacteria
caus
whippl
diseas
difficult
cultur
cn
manifest
whippl
diseas
includ
subacut
alter
mental
statu
memori
impair
ophthalmoplegia
seizur
often
set
system
gastrointestin
joint
symptom
gener
whippl
diseas
detect
duoden
biopsi
periodicacid
schiff
stain
recommend
obtain
multipl
biopsi
ensur
affect
area
miss
cn
involv
diagnos
pcr
csf
tissu
recommend
use
two
assay
target
differ
gene
improv
specif
l
monocytogen
caus
mening
meningoenceph
patient
even
mild
immun
compromis
well
rhombenceph
brainstem
cerebellar
involv
immunocompet
patient
listeria
gramposit
rod
characterist
microscop
appear
seen
gram
stain
approxim
patient
csf
cultur
report
sensit
practic
low
blood
cultur
inform
posit
variabl
sensit
rang
csf
pcr
therefor
import
addit
test
especi
patient
receiv
prior
antibiot
one
studi
listeria
pcr
posit
nine
nine
csf
cultureposit
case
well
five
csf
cultureneg
case
patient
receiv
prior
antibiot
anoth
studi
csf
pcr
posit
patient
includ
one
patient
neg
cultur
csf
blood
mycoplasma
pneumonia
caus
enceph
asept
mening
transvers
myeliti
acut
dissemin
encephalomyel
guillainbarr
syndrom
sensit
pcr
csf
report
augment
test
respiratori
tract
specimen
howev
true
perform
pcr
uncertain
due
lack
standard
methodolog
mani
case
may
reflect
postinfecti
immunemedi
diseas
therefor
serolog
aid
diagnosi
requir
acut
convalesc
sampl
sinc
patient
may
prior
infect
recommend
xpert
mtbrif
ultra
assay
cepheid
sunnyval
ca
test
choic
diagnosi
mening
due
mycobacterium
tuberculosi
test
shown
larg
multin
prospect
cohort
studi
sensit
definit
tb
mening
sensit
probabletodefinit
diseas
quit
challeng
identifi
caus
agent
patient
suspect
cn
infect
use
standard
approach
describ
clinician
must
consid
likelihood
potenti
pathogen
order
appropri
test
work
limit
volum
csf
addit
time
consum
approach
often
ineffect
etiolog
identifi
patient
enceph
mening
moreov
cost
workup
estim
per
patient
therefor
consider
interest
broadrang
assay
offer
potenti
identifi
multipl
pathogen
singl
test
common
exampl
broadrang
test
includ
amplif
sequenc
bacteria
intern
transcrib
spacer
fungi
success
use
cn
infect
signific
limit
detect
virus
multiplex
pcr
offer
intermedi
target
pcr
test
unbias
platform
assess
predetermin
set
pathogen
highli
associ
cn
infect
biofir
filmarray
meningitisenceph
panel
famep
multiplex
pcr
assay
fdaapprov
rapid
diagnosi
commun
acquir
cn
infect
panel
test
six
bacteria
escherichia
coli
capsular
subtyp
haemophilu
influenza
l
monocytogen
n
meningitidi
streptococcu
agalactia
pneumonia
seven
virus
vzv
cmv
enteroviru
parechoviru
one
fungu
c
neoformansgattii
assay
requir
minut
hand
time
close
system
perform
nucleic
acid
extract
purif
follow
twostag
amplif
increas
specif
result
return
minut
platform
gener
great
interest
due
eas
use
rapid
turnaround
time
hand
studi
evalu
perform
one
larg
industryfund
multicent
studi
sever
small
case
seri
investig
perform
famep
rel
tradit
singleplex
pcr
assay
cultur
studi
leber
et
al
prospect
csf
sampl
analyz
famep
pediatr
adult
patient
lp
bacteri
cultur
clinic
indic
overal
sampl
posit
famep
posit
test
among
pediatr
patient
adult
famep
result
concord
tradit
method
posit
sampl
falseposit
rate
bacteria
pneumonia
virus
valu
declin
respect
secondari
adjud
fals
neg
rare
occur
sampl
contain
enteroviru
agalactia
neg
predict
agreement
measur
specif
use
absenc
gold
standard
compar
high
recent
retrospect
studi
compar
perform
famep
tradit
test
posit
csf
sampl
collect
mayo
clinic
year
eighti
sampl
contain
bacteria
overal
posit
predict
agreement
ppa
measur
sensit
use
absenc
gold
standard
compar
vari
pathogen
ppa
enteroviru
cmv
vzv
pneumonia
n
meningitidi
h
influenza
cryptococcu
import
note
sampl
either
studi
l
monocytogen
n
meningitidi
agalactia
e
coli
parechoviru
cmv
sever
smaller
retrospect
case
seri
reinforc
valu
famep
detect
virus
highlight
uncertainti
identif
bacteria
use
famep
suspect
cryptococc
mening
fulli
defin
famep
high
rate
fals
posit
cryptococcu
area
low
hiv
preval
report
reliabl
csf
cryptococc
antigen
area
high
hiv
preval
highli
concord
quantit
cultur
latter
characterist
offer
potenti
use
case
famep
could
rapidli
differenti
patient
recurr
cryptococc
mening
versu
immun
reconstitut
set
antiretrovir
therapi
import
note
case
report
two
nonimmunocompromis
patient
falseneg
result
cryptococcu
famep
eas
use
rapid
turnaround
time
attract
featur
famep
test
characterist
indic
yet
replac
tradit
test
publish
literatur
suggest
primari
role
platform
test
common
virus
healthi
popul
particularli
pediatr
patient
posit
neg
predict
valu
bacteri
fungal
infect
remain
unclear
identifi
mani
pathogen
commonli
affect
neurosurg
sever
immunocompromis
patient
includ
region
pathogen
borrelia
coccidioid
wnv
addit
care
consider
must
given
pathogen
associ
chronic
infect
reactiv
herpesvirus
sinc
detect
presenc
alway
indic
pathogenesi
exampl
green
et
al
review
patient
detect
famep
determin
one
patient
clinic
syndrom
like
attribut
two
patient
possibl
culprit
deem
unlik
play
caus
role
final
remain
unclear
interpret
clinic
signific
multipl
potenti
pathogen
singl
sampl
reason
microbespecif
test
perform
confirm
set
unexpect
posit
neg
result
incumb
upon
clinic
laboratori
provid
assist
review
result
avoid
error
clinic
decis
make
metagenom
sequenc
rel
unbias
approach
whose
aim
detect
pathogen
use
singl
method
techniqu
nucleic
acid
sampl
sequenc
simultan
use
shotgun
approach
result
unbias
sequenc
read
deplet
human
read
compar
refer
databas
identifi
potenti
pathogen
metagenom
sequenc
librari
creat
directli
dna
identifi
eukaryot
bacteria
dna
virus
detect
rna
virus
rna
first
revers
transcrib
complementari
dna
use
random
primer
metagenom
sequenc
librari
gener
method
depict
describ
greater
detail
sever
recent
review
past
year
seen
explos
use
metagenom
sequenc
detect
discov
pathogen
much
work
done
patient
cn
infect
sinc
csf
steril
fluid
lack
commens
microb
rel
low
background
host
nucleic
acid
compar
specimen
type
case
report
highlight
capac
metagenom
sequenc
detect
pathogen
belong
differ
kingdom
exampl
includ
bacteria
leptospira
brucella
fungi
candida
tropicali
protozoa
balamuthia
virus
wnv
hepat
e
viru
addit
csf
metagenom
sequenc
success
detect
pathogen
brain
tissu
bloodstream
patient
brain
abscess
due
scedosporium
although
much
work
conduct
research
set
multipl
case
report
demonstr
clinic
util
rapid
metagenom
sequenc
case
report
highlight
remark
strength
metagenom
sequenc
compar
standard
test
pathogen
commonli
diagnos
serolog
metagenom
sequenc
offer
faster
turnaround
time
achiev
diagnosi
patient
antibodi
unreli
eg
due
treatment
rituximab
pathogen
detect
pcr
metagenom
sequenc
offer
advantag
high
sensit
independ
pathogenspecif
primer
highlight
benefit
use
unbias
approach
metagenom
sequenc
yield
unexpect
find
immunocompromis
patient
includ
coronaviru
cach
valley
viru
mump
vaccineassoci
enceph
even
identifi
novel
pathogen
appli
broadli
metagenom
sequenc
help
reveal
import
underappreci
pathogen
astroviru
addit
direct
diagnost
use
metagenom
sequenc
also
provid
inform
pathogen
genom
molecular
epidemiolog
howev
despit
mani
strength
also
limit
metagenom
sequenc
importantli
reli
upon
presenc
pathogen
nucleic
acid
sampl
test
discuss
cn
syndrom
believ
caus
pathogen
result
immun
respons
metagenom
sequenc
detect
antibodymedi
process
virus
replic
short
durat
cn
eg
wnv
detect
metagenom
sequenc
routin
may
easili
detect
immunocompromis
patient
due
longer
viral
replic
ad
challeng
case
util
metagenom
sequenc
predict
ahead
time
exampl
enteroviru
readili
detect
metagenom
sequenc
case
mening
contrast
mani
recent
patient
afm
enteroviru
detect
csf
rna
detect
respiratori
sampl
believ
caus
pathogen
afm
second
limit
metagenom
sequenc
high
sensit
lead
high
background
microb
present
patient
skin
laboratori
reagent
lead
need
care
interpret
result
stringent
use
neg
control
exampl
salzberg
et
al
detect
sequenc
read
delftia
elizabethkingia
brain
tissu
sampl
one
patient
mening
anoth
brain
mass
respect
author
appropri
skeptic
causal
role
agent
caus
observ
diseas
later
studi
demonstr
read
delftia
elizabethkingia
organ
present
mani
neg
control
sampl
suggest
use
statist
score
techniqu
distinguish
signal
nois
metagenom
sequenc
move
clinic
practic
becom
increasingli
import
defin
test
characterist
detail
use
neg
control
defin
specif
well
valid
studi
definit
sensit
valid
metagenom
sequenc
challeng
unlik
tradit
test
multitud
possibl
outcom
possibl
valid
everi
potenti
pathogen
therefor
propos
valid
subset
organ
repres
differ
gener
characterist
eg
virus
differ
genom
structur
bacteria
differ
cellwal
type
use
sampl
patient
confirm
infect
well
mock
sampl
creat
vitro
silico
approach
describ
csf
well
respiratori
sampl
report
overal
sensit
order
specif
use
mock
sampl
limit
detect
variou
organ
estim
rang
copiesml
virus
order
cfuml
bacteria
cfuml
fungi
factor
contribut
low
sensit
includ
low
level
pathogen
nucleic
acid
high
level
host
nucleic
acid
background
poor
match
particular
pathogen
genom
repres
includ
refer
databas
like
variabl
factor
type
pathogen
eg
enteroviru
versu
wnv
also
specif
pathogen
type
differ
host
eg
wnv
immunocompet
vs
immunocompromis
patient
factor
contribut
low
specif
includ
contamin
organ
patient
skin
microb
compon
present
reagent
contamin
laboratori
environ
sampl
includ
sequenc
run
fals
posit
also
result
comput
analysi
poor
specif
comput
pipelin
eg
classifi
bacteria
level
genu
misclassif
refer
databas
despit
challeng
recent
consider
success
establish
clinic
valid
pipelin
metagenom
sequenc
cn
respiratori
infect
also
activ
area
interest
industri
like
metagenom
sequenc
take
increasingli
import
role
diagnosi
infecti
diseas
given
limit
describ
appli
result
metagenom
sequenc
clinic
practic
involv
care
interpret
context
specif
patient
organ
yet
valid
confirmatori
test
use
standard
assay
employ
possibl
current
metagenom
sequenc
often
use
last
resort
patient
extens
test
unrev
import
consid
whether
would
fruit
frontlin
test
could
potenti
replac
standard
pcr
common
pathogen
detect
rare
pathogen
without
extens
addit
workup
perhap
higher
yield
appli
higher
qualiti
ie
fresh
specimen
current
approach
diagnosi
cn
infect
complex
incorpor
tradit
test
cultur
serolog
direct
pcr
well
newer
broadrang
test
multiplex
pcr
metagenom
sequenc
broadrang
test
offer
excit
opportun
detect
mani
potenti
pathogen
expect
improv
overal
rate
diagnosi
patient
cn
infect
howev
test
characterist
costbenefit
ratio
method
still
evalu
routin
use
requir
cognit
shift
among
clinician
lessen
emphasi
think
potenti
pathogen
ahead
time
increas
need
care
interpret
result
